Journal of Translational Medicine, 2023 · DOI: https://doi.org/10.1186/s12967-023-04414-x · Published: August 2, 2023
Peripheral nerve injury can cause neuroinflammation and neuromodulation that lead to mitochondrial dysfunction and neuronal apoptosis in the dorsal root ganglion (DRG) and spinal cord, contributing to neuropathic pain and motor dysfunction. Hyperbaric oxygen therapy (HBOT) has been suggested as a potential therapeutic tool for neuropathic pain and nerve injury. HBOT during the early phase of the SNC alleviates mechanical and thermal hypersensitivity and motor dysfunction.
HBOT could be a non-invasive therapy for managing neuropathic pain and motor dysfunction.
HBOT offers neuroprotection by reducing inflammation, apoptosis, and mitochondrial dysfunction.
HBOT's benefits are linked to modulation of neuroinflammation, neuromodulation, and preservation of mitochondrial function.